Roka Bioscience Pulls in $20 Million

Xconomy New York — 

Roka Bioscience, a Warren, NJ-based of diagnostic tools for industrial markets, raised $20 million in a Series C, according to a press release. Roka’s lead product—an assay for food-safety testing—is expected to hit the market later this year. Roka was formed in 2009 as a spinoff from Gen-Probe (NASDAQ: GPRO), a San Diego-based maker of diagnostic tools. All of Roka’s previous investors participated in this round, including Gen-Probe, OrbiMed Advisors, New Enterprise Associates, and TPG Biotech.